Inhalation administration in form of e.g. hypertonic solutions, useful for the removal of bronchial secretions, comprises an osmolar-acting agent e.g. sodium chloride, and hyaluronic acid, suspect preservatives or pharmaceutical excipients
Inhalation administration in the form of hypertonic solutions or dry powders, comprises an osmolar-acting agent of either sodium chloride or mannitol, and hyaluronic acid of biotechnical origin with low molecular weight, or its salt, suspect preservatives or pharmaceutical excipients.L'invention concerne des formulations d'inhalation sous forme de solutions hypertoniques ou de poudres sèches contenant un agent osmolarisant choisi parmi le NaCl ou le mannitol, et de l'acide hyaluronique d'origine biotechnologique à faible masse moléculaire ou son sel, dénuées de conservateurs ou excipients.